Homeownership Programs, New Apps for Mortgage and Real Estate Professionals, Dividend, and Market Activity - Research Reports on Radian, Banco Santander, BioMed Realty, Chimera and Genworth

NEW YORK, October 17, 2014 /PRNewswire/ --

Today, Analysts Review released its research reports regarding Radian Group Inc. (NYSE: RDN), Banco Santander, S.A. (NYSE: SAN), BioMed Realty Trust Inc. (NYSE: BMR), Chimera Investment Corporation (NYSE: CIM) and Genworth Financial, Inc. (NYSE: GNW). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/7255-100free.

--
Radian Group Inc. Research Reports
On October 14, 2014, Radian Group Inc. (Radian) announced a new Company-sponsored program, which assists potential homeowners by providing them with the requisite resources to begin the path towards a sustainable and responsible homeownership. The program titled 'Ready, Set, Own!' is first implemented in the Tuscan area, but may expand to additional communities across the U.S, said Radian. According to Radian, the program will strive to bring together local housing, lending and credit counseling resources so as to develop a personalized plan that results in successful homeownership for anyone wishing to buy a home. Commenting on the initiative, S.A. Ibrahim, CEO of Radian, said, "At Radian, our goal is to help people from all walks of life and all financial backgrounds to responsibly achieve that dream, but we know it isn't always easy. Potential homebuyers sometimes need resources and guidance to help them on their way, and the Ready, Set, Own! campaign is designed to empower them with the knowledge and preparation they need to turn homeownership into a reality." The full research reports on Radian are available to download free of charge at:

http://www.analystsreview.com/Oct-17-2014/RDN/report.pdf

--
Banco Santander, S.A. Research Reports
On October 14, 2014, the ADRs of Banco Santander, S.A. (Banco Santander) gained for the second consecutive session and ended at $9.02, up 1.01% from its previous day's close. The ADR opened at $8.98 and fluctuated between $8.95 and $9.11, with a total of 8.26 million shares changing hands. The ADR has a 52-week low of $8.31 and a 52-week high of $10.75. The bank is scheduled to pay a quarterly dividend of $0.188955 per share on November 13, 2014 to shareholders of record as of October 17, 2014. The full research reports on Banco Santander are available to download free of charge at:

http://www.analystsreview.com/Oct-17-2014/SAN/report.pdf

--
BioMed Realty Trust Inc. Research Reports
On October 13, 2014, BioMed Realty Trust, Inc. (BioMed Realty) launched industry's maiden mobile application on the Apple platform, which provides tenants and brokers with a comprehensive overview of the Company's four new development opportunities in Boston/Cambridge, San Francisco, San Diego and Seattle. Kent Griffin, President & Chief Operating Officer, BioMed Realty said, "We are proud to deliver this innovative tool to support our brokers and tenants, which serves to illustrate the value and experiences of our four development opportunities, each well-located in the heart of a leading research hub and expected to offer fantastic amenities." According to the Company, the new application provides users with a number of experiences to understand the value and opportunities available at BioMed Realty's aforementioned projects. The Company will also launch an upgraded version of this app later this year, which will include all the BioMed Realty properties including the entire Wexford Science + Technology portfolio. The full research reports on BioMed Realty are available to download free of charge at:

http://www.analystsreview.com/Oct-17-2014/BMR/report.pdf

--
Chimera Investment Corporation Research Reports
On September 17, 2014, the Board of Directors of Chimera Investment Corporation (Chimera) declared a Q3 2014 cash dividend of $0.09 per common share, payable October 29, 2014, to common shareholders of record on September 30, 2014. In addition, the Board of Directors reviewed the dividend program and resolved to pay a similar dividend of $0.09 per share for Q4 2014 as well. The full research reports on Chimera are available to download free of charge at:

http://www.analystsreview.com/Oct-17-2014/CIM/report.pdf

--
Genworth Financial, Inc. Research Reports
On October 2, 2014, Genworth Financial, Inc. (Genworth) unveiled a mobile application which provides mortgage professionals with all the information they need to help their clients make sound homebuying decisions. Launched by Genworth Canada, the HomeOpeners application provides an estimate of what homeowners can actually afford by including additional expenses, such as property taxes, monthly utilities and mortgage insurance premiums. Commenting on the launch, Debbie McPherson, Senior Vice President, Sales & Marketing with Genworth Canada, said, "Our goal when designing this new app was to create an all-encompassing mobile tool that could easily allow our customers to provide their clients with the necessary information to better understand their options so they can make sound decisions." The full research reports on Genworth are available to download free of charge at:

http://www.analystsreview.com/Oct-17-2014/GNW/report.pdf

--
About Analysts Review
We do things differently. Our goal is to provide the best content to our exclusive membership. We are constantly hiring researchers, writers, editors and analysts to add to our team and become better than yesterday. If being a part of a fast growing community with an edge in today's market sounds interesting to you, then sign-up today and experience the full benefits of membership.


===============
EDITOR'S NOTES:
===============

1. This is not company news. We are an independent source and our views do not reflect the companies mentioned.

2. Information in this release is produced on a best efforts basis by Rohit Tuli, a CFA charterholder. The content is then further fact checked and reviewed by an outsourced research provider. However, we are only human and are prone to make mistakes. If you notice any errors or omissions, please notify us below.

3. This information is submitted as a net-positive to companies mentioned, to increase awareness for mentioned companies to our subscriber base and the investing public.

4. If you wish to have your company covered in more detail by our team, or wish to learn more about our services, please contact us at pubco [at] www.analystsreview.com.

5. For any urgent concerns or inquiries, please contact us at compliance [at] www.analystsreview.com.

6. Are you a public company? Would you like to see similar coverage on your company? Send us a full investors' package to research [at] www.analystsreview.com for consideration.

COMPLIANCE PROCEDURE
Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Analysts Review, represented by Rohit Tuli, CFA. An outsourced research services provider has only reviewed the information provided by Analysts Review in this article or report according to the procedures outlined by Analysts Review. Analysts Review is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be.

NOT FINANCIAL ADVICE
Analysts Review makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein.

NO WARRANTY OR LIABILITY ASSUMED
Analysts Review is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by Analysts Review whatsoever for any direct, indirect or consequential loss arising from the use of this document. Analysts Review expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Analysts Review does not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE Analysts Review